Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Andrea Dennis, Malgorzata Wamil, Johann Alberts, Jude Oben, Daniel J Cuthbertson, Dan Wootton, Michael Crooks, Mark Gabbay, Michael Brady, Lyth Hishmeh, Emily Attree, Melissa Heightman, Rajarshi Banerjee, Amitava Banerjee, COVERSCAN study investigators, Andrea Dennis, Malgorzata Wamil, Johann Alberts, Jude Oben, Daniel J Cuthbertson, Dan Wootton, Michael Crooks, Mark Gabbay, Michael Brady, Lyth Hishmeh, Emily Attree, Melissa Heightman, Rajarshi Banerjee, Amitava Banerjee, COVERSCAN study investigators
Abstract
Objective: To assess medium-term organ impairment in symptomatic individuals following recovery from acute SARS-CoV-2 infection.
Design: Baseline findings from a prospective, observational cohort study.
Setting: Community-based individuals from two UK centres between 1 April and 14 September 2020.
Participants: Individuals ≥18 years with persistent symptoms following recovery from acute SARS-CoV-2 infection and age-matched healthy controls.
Intervention: Assessment of symptoms by standardised questionnaires (EQ-5D-5L, Dyspnoea-12) and organ-specific metrics by biochemical assessment and quantitative MRI.
Main outcome measures: Severe post-COVID-19 syndrome defined as ongoing respiratory symptoms and/or moderate functional impairment in activities of daily living; single-organ and multiorgan impairment (heart, lungs, kidneys, liver, pancreas, spleen) by consensus definitions at baseline investigation.
Results: 201 individuals (mean age 45, range 21-71 years, 71% female, 88% white, 32% healthcare workers) completed the baseline assessment (median of 141 days following SARS-CoV-2 infection, IQR 110-162). The study population was at low risk of COVID-19 mortality (obesity 20%, hypertension 7%, type 2 diabetes 2%, heart disease 5%), with only 19% hospitalised with COVID-19. 42% of individuals had 10 or more symptoms and 60% had severe post-COVID-19 syndrome. Fatigue (98%), muscle aches (87%), breathlessness (88%) and headaches (83%) were most frequently reported. Mild organ impairment was present in the heart (26%), lungs (11%), kidneys (4%), liver (28%), pancreas (40%) and spleen (4%), with single-organ and multiorgan impairment in 70% and 29%, respectively. Hospitalisation was associated with older age (p=0.001), non-white ethnicity (p=0.016), increased liver volume (p<0.0001), pancreatic inflammation (p<0.01), and fat accumulation in the liver (p<0.05) and pancreas (p<0.01). Severe post-COVID-19 syndrome was associated with radiological evidence of cardiac damage (myocarditis) (p<0.05).
Conclusions: In individuals at low risk of COVID-19 mortality with ongoing symptoms, 70% have impairment in one or more organs 4 months after initial COVID-19 symptoms, with implications for healthcare and public health, which have assumed low risk in young people with no comorbidities.
Trial registration number: NCT04369807; Pre-results.
Keywords: COVID-19; epidemiology; health policy; public health.
Conflict of interest statement
Competing interests: AD, RB and MB are employees of Perspectum.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Figures
References
- World Health Organization . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. interim guidance 13 March 2020, 2020. Available:
- Pavon AG, Meier D, Samim D, et al. . First documentation of persistent SARS-Cov-2 infection presenting with late acute severe myocarditis. Can J Cardiol 2020;36:1326.e5–1326.e7. 10.1016/j.cjca.2020.06.005
- Puntmann VO, Carerj ML, Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2019;2020:1265–73.
- Tabary M, Khanmohammadi S, Araghi F, et al. . Pathologic features of COVID-19: a Concise review. Pathol Res Pract 2020;216:153097. 10.1016/j.prp.2020.153097
- Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United European Gastroenterol J 2020;8:509–19. 10.1177/2050640620924157
- Somasundaram NP, Ranathunga I, Ratnasamy V, et al. . The impact of SARS-Cov-2 virus infection on the endocrine system. J Endocr Soc 2020;4:1–22. 10.1210/jendso/bvaa082
- Farouk SS, Fiaccadori E, Cravedi P, et al. . COVID-19 and the kidney: what we think we know so far and what we don't. J Nephrol 2020;33:1213–8. 10.1007/s40620-020-00789-y
- Lai A, Pasea L, Banerjee A. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. BMJ Open 2020;10:e043828.
- Banerjee A, Pasea L, Harris S, et al. . Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet 2020;395:1715–25. 10.1016/S0140-6736(20)30854-0
- Banerjee A, Chen S, Pasea L. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol 2020. 10.1093/eurjpc/zwaa155
- Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-Term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683
- Horton R. Offline: COVID-19 is not a pandemic. The Lancet 2020;396:874. 10.1016/S0140-6736(20)32000-6
- Shovlin CL, Vizcaychipi MP. Implications for COVID-19 triage from the ICNARC report of 2204 COVID-19 cases managed in UK adult intensive care units. Emerg Med J 2020;37:332–3. 10.1136/emermed-2020-209791
- Docherty AB, Harrison EM, Green CA, et al. . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985–12. 10.1136/bmj.m1985
- Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430–6. 10.1038/s41586-020-2521-4
- Office for National Statistics . The prevalence of long COVID symptoms and COVID-19 complications, 2020. Available:
- del Rio C, Collins LF, Malani P. Long-Term health consequences of COVID-19. JAMA 2020;324:1723. 10.1001/jama.2020.19719
- Carfì A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603–5. 10.1001/jama.2020.12603
- Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020;370:m3489. 10.1136/bmj.m3489
- Greenhalgh T, Knight M, A’Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;13:m3026. 10.1136/bmj.m3026
- National Institute for Health Research . New risk prediction model could help improve guidance for people shielding from COVID-19, 2020. Available:
- Hill AD, Fowler RA, Pinto R, et al. . Long-term outcomes and healthcare utilization following critical illness – a population-based study. Crit Care 2016;20:1–10. 10.1186/s13054-016-1248-y
- Perrin R, Riste L, Hann M, et al. . Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses 2020;144:110055. 10.1016/j.mehy.2020.110055
- George PM, Barratt SL, Condliffe R, et al. . Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 2020;75:1009–16. 10.1136/thoraxjnl-2020-215314
- Jiang DH, McCoy RG. Planning for the Post-COVID syndrome: how payers can mitigate long-term complications of the pandemic. J Gen Intern Med 2020;35:3036–9. 10.1007/s11606-020-06042-3
- Janssen MF, Pickard AS, Golicki D, et al. . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717–27. 10.1007/s11136-012-0322-4
- Yorke J, Moosavi SH, Shuldham C, et al. . Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21–6. 10.1136/thx.2009.118521
- Hobbins A, Barry L, Kelleher D, et al. . The health of the residents of ireland: population norms for Ireland based on the EQ-5D-5L descriptive system – a cross sectional study. HRB Open Res 2018;1:22. 10.12688/hrbopenres.12848.1
- Gupta A, Madhavan MV, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017–32. 10.1038/s41591-020-0968-3
- Palmer K, Monaco A, Kivipelto M, et al. . The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res 2020;32:1189–94. 10.1007/s40520-020-01601-4
- Menni C, Valdes AM, Freidin MB, et al. . Real-Time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 2020;26:1037–40. 10.1038/s41591-020-0916-2
- Mandal S, Barnett J, Brill S, et al. . “Long-COVID”: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2020:thoraxjnl-2020-215818.
- Chau VQ, Giustino G, Mahmood K, et al. . Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Hear Fail 2020:556–9.
- Rajpal S, Tong MS, Borchers J, et al. . Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2020:5–7.
- Mathew D, Giles JR, Baxter AE, et al. . Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 2020;369:eabc8511. 10.1126/science.abc8511
- Wynants L, Van Calster B, Collins GS, et al. . Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020;369:m1328.
- PHOSP-COVID . Post-HOSPitalisation COVID-19 study, 2020. Available:
- NHS . NHS to offer ‘long covid’ sufferers help at specialist centres, 2020. Available:
- National Institute for Healh and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020. Available:
- Ferreira VM, Piechnik SK, Dall’Armellina E, et al. . Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014;16:1–11. 10.1186/1532-429X-16-36
- Gibson LM, Paul L, Chappell FM, et al. . Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis. BMJ 2018;14:k4577. 10.1136/bmj.k4577
Source: PubMed